Advertisement Halo Pharmaceutical names new vice president of business development - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Halo Pharmaceutical names new vice president of business development

Halo Pharmaceutical, a specialty pharmaceutical company, has appointed Allen Rosenston as its new vice president of business development.

Mr Rosenston comes to Halo from a long and distinguished career at Abbott Laboratories where he held diverse roles in operations, business development, and related business functions.

Mohd Asif, CFO of Halo, said: “The addition of Al to the Halo business development team is a significant achievement. Al has deep experience within the pharmaceutical industry. He developed Abbott’s domestic contract pharmaceutical manufacturing business unit and, at the time of his retirement, he was responsible for the global finished goods contract manufacturing business.”